# FAST-A Study to Evaluate the Efficacy and Safety of Quetiapin IR in Patients With Acute Psychosis

> **NCT00486798** · PHASE3 · TERMINATED · sponsor: **AstraZeneca**

## Conditions studied

- Psychotic Disorders
- Schizophrenia
- Bipolar Disorder

## Interventions

- **DRUG:** Quetiapine
- **PROCEDURE:** Rating Scales
- **PROCEDURE:** Self Assessment Form
- **PROCEDURE:** Blood and urine samples
- **PROCEDURE:** Sleeping pattern

## Key facts

- **NCT ID:** NCT00486798
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-05
- **Primary completion:** 2007-08
- **Final completion:** 2007-08
- **Target enrollment:** — (—)
- **Why stopped:** study was not ethically acceptable to continue and therefore it was finally stopped
- **Last updated:** 2010-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00486798

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00486798, "FAST-A Study to Evaluate the Efficacy and Safety of Quetiapin IR in Patients With Acute Psychosis". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00486798. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*